| scholarly article | Q13442814 |
| P50 | author | Romina Bertinat | Q73847609 |
| P2093 | author name string | Francisco Nualart | |
| Xuhang Li | |||
| Alejandro J Yáñez | |||
| Elizabeth Mann | |||
| Pamela Silva | |||
| P2860 | cites work | An application of population kinetics analysis to estimate pharmacokinetic parameters of sodium tungstate after multiple-dose during preclinical studies in rats. | Q52038356 |
| Altered expression and localization of insulin receptor in proximal tubule cells from human and rat diabetic kidney. | Q54478096 | ||
| Interstitial vascular rarefaction and reduced VEGF-A expression in human diabetic nephropathy. | Q60748236 | ||
| Autocrine and paracrine functions of vascular endothelial growth factor (VEGF) in renal tubular epithelial cells | Q81324707 | ||
| Tungstate is an effective antidiabetic agent in streptozotocin-induced diabetic rats: a long-term study | Q28564460 | ||
| Histone deacetylase-2 is a key regulator of diabetes- and transforming growth factor-beta1-induced renal injury | Q28569252 | ||
| Evidence that fibroblasts derive from epithelium during tissue fibrosis | Q29616581 | ||
| TGF-beta signaling and the fibrotic response | Q29620099 | ||
| Effects of tungstate, a new potential oral antidiabetic agent, in Zucker diabetic fatty rats. | Q31809629 | ||
| Hypoxia response and VEGF-A expression in human proximal tubular epithelial cells in stable and progressive renal disease | Q33399420 | ||
| Molecular mechanisms of tungstate-induced pancreatic plasticity: a transcriptomics approach. | Q33498114 | ||
| VEGF ameliorates tubulointerstitial fibrosis in unilateral ureteral obstruction mice via inhibition of epithelial-mesenchymal transition | Q33566806 | ||
| VEGF suppresses epithelial-mesenchymal transition by inhibiting the expression of Smad3 and miR‑192, a Smad3-dependent microRNA. | Q34669810 | ||
| The proximal tubule in the pathophysiology of the diabetic kidney | Q34979592 | ||
| Preclinical and Clinical Studies for Sodium Tungstate: Application in Humans. | Q35618949 | ||
| New insights into epithelial-mesenchymal transition in kidney fibrosis | Q36010095 | ||
| Phenotypic transitions and fibrosis in diabetic nephropathy | Q36753326 | ||
| Role of Kruppel-like factor 6 in transforming growth factor-beta1-induced epithelial-mesenchymal transition of proximal tubule cells | Q36977366 | ||
| Epithelial-mesenchymal crosstalk alteration in kidney fibrosis | Q38008613 | ||
| The renal endothelium in diabetic nephropathy | Q38087656 | ||
| Proof‐of‐concept trial on the efficacy of sodium tungstate in human obesity | Q38499372 | ||
| Over-expression of muscle glycogen synthase in human diabetic nephropathy | Q38942613 | ||
| Reactive-oxygen-species-mediated Cdc25C degradation results in differential antiproliferative activities of vanadate, tungstate, and molybdate in the PC-3 human prostate cancer cell line | Q39455819 | ||
| Circulating bone morphogenetic protein-7 and transforming growth factor-β1 are better predictors of renal end points in patients with type 2 diabetes mellitus | Q39504175 | ||
| Monocytes induce proximal tubular epithelial-mesenchymal transition through NF-kappa B dependent upregulation of ICAM-1. | Q39587424 | ||
| Phosphorylation events implicating p38 and PI3K mediate tungstate-effects in MIN6 beta cells | Q40134927 | ||
| Connective tissue growth factor plays an important role in advanced glycation end product-induced tubular epithelial-to-mesenchymal transition: implications for diabetic renal disease. | Q40242733 | ||
| Effects of high glucose and TGF-beta1 on the expression of collagen IV and vascular endothelial growth factor in mouse podocytes | Q40712583 | ||
| ERK, p38, and Smad signaling pathways differentially regulate transforming growth factor-beta1 autoinduction in proximal tubular epithelial cells. | Q41091738 | ||
| PI3-kinase and TGF-β in glomerular nephropathy: which comes first? | Q43071537 | ||
| Transforming growth factor-beta2 antibody attenuates fibrosis in the experimental diabetic rat kidney | Q43721105 | ||
| Enhancement of in vitro human tubulogenesis by endothelial cell-derived factors: implications for in vivo tubular regeneration after injury. | Q43776037 | ||
| Immunomodulatory effect of tungstate on streptozotocin-induced experimental diabetes in rats | Q44000585 | ||
| Epithelial-mesenchymal transition of tubular epithelial cells in human renal biopsies | Q44039616 | ||
| TGF-beta isoforms in renal fibrogenesis | Q44544997 | ||
| The antidiabetic agent sodium tungstate activates glycogen synthesis through an insulin receptor-independent pathway. | Q44553715 | ||
| Human antigen R mediated post-transcriptional regulation of epithelial-mesenchymal transition related genes in diabetic nephropathy. | Q51694546 | ||
| Role of peritubular capillary loss and hypoxia in progressive tubulointerstitial fibrosis in a rat model of aristolochic acid nephropathy. | Q51793468 | ||
| P433 | issue | 10 | |
| P304 | page(s) | 2437-2446 | |
| P577 | publication date | 2015-10-01 | |
| P1433 | published in | Journal of Cellular Physiology | Q1524270 |
| P1476 | title | In vivo sodium tungstate treatment prevents E-cadherin loss induced by diabetic serum in HK-2 cell line | |
| P478 | volume | 230 |
Search more.